RxDoctor Payments Data
★ My doctorsLook up a doctor →

Cesar Pena-Rodriguez

Internal Medicine · Garland, TXNPI 1073576435

Payments from drug & device makers

$1,493in general payments, 2019–2025

Across 98 payments — averaging $15.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$357
  • Boehringer Ingelheim$212
  • AstraZeneca$210
  • Amgen$209
  • Novo Nordisk$124
  • Merck$76
  • plus $305 from 13 others

What the payments were for

  • Food & beverage$1,493100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson24$357
Boehringer Ingelheim12$212
AstraZeneca14$210
Amgen(2 entities)14$209
Novo Nordisk8$124
Merck5$76
Lilly USA, LLC3$50
Pfizer2$47
Almatica Pharma LLC2$31
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC2$29
Optinose US, Inc.2$23
Genentech USA, Inc.1$23
Paratek Pharmaceuticals, Inc.1$19
Alfasigma USA, Inc.1$16
GSK1$15
Takeda Pharmaceuticals U.S.A., Inc.3$14
Currax Pharmaceuticals LLC1$13
Scilex Pharmaceuticals Inc.1$12
Sanofi-aventis U.S. LLC1$12

How this compares

$1,493 in reported general payments places this provider in the 70th percentile of 7,675 internal medicine providers in Texas.

See all internal medicine providers in Texas →

Other internal medicine in Garland

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →